Livento Group (NUGN) Releases Q3 Financial results
NuGene International, Inc. (OTC Pink: NUGN) reported its Q3 2022 results, highlighting total assets of $24.4 million and a revenue increase of $515,120, marking over 30% growth year-to-date. Adjusted EBITDA stood at $114,149. The company enhanced its content library and increased marketing visibility. Despite some administrative costs amounting to $400,971, the balance sheet remains debt-free, supporting future growth. Looking ahead, substantial revenue and EBITDA increases are anticipated in Q4 2022.
- Assets increased by 4% to $24,444,245.
- Total revenue grew by over 30% YTD to $515,120.
- EBITDA was in line with expectations at $114,149.
- No significant debts or liabilities, reflecting a strong balance sheet.
- Administrative costs increased due to one-off expenses totaling $400,971.
New York, NY, Oct. 27, 2022 (GLOBE NEWSWIRE) -- NuGene International, Inc./Livento Group, Inc. (OTC Pink: NUGN) is a dynamic group that specializes in acquiring and developing companies with disruptive business models in film, content and technology for fund managers. This quarter's results are our third full quarter and the first as a fully reporting company.
Highlights for the three months ending September 30th, 2022, are as follows:
- Assets:
$24,444,245 - Revenue:
$515,120 - EBITDA:
$114,149
Progress during the third quarter saw fresh investments in new and current titles so that they move through the development cycle, and we saw steady progression across all areas of our business. We have continued to divest from Real estate and allocate those funds to BOXO Productions. The group increased its visibility significantly across a number of channels with appearances in podcasts such as Benzinga and an increased focus on social media leading the marketing charge.
The Groups Progress during the third quarter was broadly in line with our expectations. The Group's Revenue increased when compared with Q2 which provides total growth of over
Investors should note that the Balance sheet remains without significant debts, and liabilities with zero items over contracted terms. This has been part of a strategy whereby we consider the business to be more attractive to large investors and investment banks that want to participate in our future growth plans.
BOXO Productions
BOXO revenues box office revenue start with Savage Salvation (previously named Wash me in the River) that should air in the cinemas within the coming months. BOXO assets and the value of the content library are steadily increasing as the titles grow in value. As they mature their asset value increases and revenue will increase as they move through the development progress before being aired.
In Quarter 3 we continued to grow the content library with these titles:
- Further investment into Carnival of Killers
- Acquired the rights to a script to start work on a new movie project, the title of which we will announce soon.
- The script for the title ‘Running Wild’ increased in value as it moves closer to the filming stage
Looking forward, we have concluded negotiations to acquire early-stage rights to new movie projects which we will announce soon. These contracts are still at the legal review stage. They will be announced when these contracts have been concluded which we anticipate being in November.
Elisee
This tool which provides a semi-automated portfolio management system to assist fund managers to outperform the market with reduced risk. The tool has performed above our expectations in conditions which have been extremely challenging when we analyzed the results in Q3 Elisee is performing
Real Estate and Advisory
We continued with the sale of Real estate assets. The value of the assets sold was
Comments from the CEO, David Stybr
In September we became a fully reporting company according to the 60-day rule, so we are reporting according to those rules with the submission of 10Q. The SEC has asked for clarification on a couple of areas and this updated filing has now been made. During the fourth quarter, Livento Group expects its valuation to be completed, the Name change to be effective on OTC markets as well as a ticker change application to be filed, and to apply to OTC Markets to uplist from the OTC Pink Market to the OTCQB.
Livento also plans to make important announcements regarding its roadmap and important milestones during the period and we are confident of an even stronger performance in the fourth quarter and 2023. Livento Groups’ CEO, David Stybr, commented: “We have delivered according to plan during the third quarter, and we are just starting to find our feet as an international company. We have a strong and stable management team which continues to grow. As we grow and attract further investment the deals that we conclude will be larger and more frequent. There is a lot happening behind the scenes evidenced by new hires that we have recently made. Companies hire when they are growing and are confident in their future. Our company, staff and shareholders can look forward to steady growth and performance.
About Livento Group, Inc.
Safe Harbor Statement:
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements as predictions, projections, or references future events and expectations, possibilities or similar. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. Although the Company believes the expectations reflected in our forward-looking statements are based on reasonable assumptions, the Company is unable to give any assurance that its expectations will be attained due to several variable factors. Factors or events that could cause actual results to differ may emerge, and it is impossible for the Company to predict all of them. Some of these risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, in customer order patterns, changes in consumer trends, and various other factors beyond the Company's control. Although the Company intends to provide public updates, it undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Contact:
David Stybr, CEO
Livento Group, Inc.
ir@liventogroup.com
Livento Group LLC | LinkedIn | Twitter
Boxo Productions | LinkedIn | Twitter | Instagram | Facebook
FAQ
What were the Q3 2022 financial results for NuGene International (NUGN)?
What is the revenue growth reported by NuGene International in 2022?
How much did NuGene International allocate to administrative expenses in Q3 2022?